Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19738242 | 1.00 | KDM4E (0.60) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL22989359 | 1.00 | KDM4E (0.60) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL11922086 | 1.00 | KDM4E (0.60) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL11922009 | 0.98 | KDM4E (0.58) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL24729779 | 0.98 | KDM4E (0.62) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL11922004 | 0.97 | KDM4E (0.56) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL11921989 | 0.97 | KDM4E (0.55) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL24514833 | 0.97 | KDM4E (0.60) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL11922019 | 0.95 | KDM4E (0.55) | KDM4EL3MBTL1ATMMAPK8HSD17B10 | |
| SCHEMBL20904347 | 0.95 | KDM4E (0.55) | KDM4EL3MBTL1ATMMAPK8HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49237-E1 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2022-10-04 | — | — | US | disclosed |
| US-10937967-B2 | Amine-based compound and organic light-emitting device including the amine-based compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-03-02 | — | — | US | disclosed |
| US-20190115543-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9172045-B2 | 4-aminocarbazole compound and use thereof | TOSOH CORPORATION (JP) | 2015-10-27 | — | — | US | disclosed |
| US-9172045-B2 | 4-aminocarbazole compound and use thereof | TOSOH CORPORATION (JP) | 2015-10-27 | — | — | US | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10937967-B2 | Amine-based compound and organic light-emitting device including the amine-based compound | AOC2, AOC1, SAT1 | KDM4E 495/4885L3MBTL1 665/4885ATM 792/4885 |
| US-20190115543-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND | AOC2, AOC1, SAT1 | KDM4E 495/4885L3MBTL1 665/4885ATM 792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.